Publications
Reading list
The tanning experiment opens several doors. These are the publications encountered along the way.
Pigmentation and erections
The pigmentation pilot and the crossover study in men with psychogenic erectile dysfunction make a good pair. The abrupt change in research question makes those my starting pair; the historical account then widens the development story.
Read the animal experiments together
The male-mouse food-motivation experiment becomes more interesting beside the rat taste-aversion study. Their experimental settings prevent an easy merger of the results. The topical melanoma study in cells and mice deserves the same attention to its specific model.
Return to the reports involving people
The review of unregulated analogue use places the mole and melanoma reports in context and preserves the uncertainty over causation. For a particularly specific pigmentation observation, the oral-mucosa case report is worth the time. I return from these papers with less appetite for a tidy verdict and more curiosity about the differences between the findings.
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study ↗
- Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study ↗
- Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization ↗
- Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food ↗
- Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report ↗
- Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide ↗
- PT-141: a melanocortin agonist for the treatment of sexual dysfunction ↗
- Eruptive dysplastic nevi following melanotan use ↗
- Melanoma associated with the use of melanotan-II ↗
- Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII. ↗
- Identification and characterization by LC-UV-MS/MS of melanotan II skin-tanning products sold illegally on the Internet. ↗
- Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review. ↗
- Melanotan II: a possible cause of renal infarction: review of the literature and case report ↗
- Melanotan II injection resulting in systemic toxicity and rhabdomyolysis ↗
- Melanotan II overdose associated with priapism ↗
- Afamelanotide for Erythropoietic Protoporphyria ↗
- Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition. ↗
- Alpha-melanocyte stimulating hormone (alpha-MSH): biology, clinical relevance and implication in melanoma ↗
- Melanotan II User Experience: A Qualitative Study of Online Discussion Forums ↗
- Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II ↗
- Melanocortin receptors, melanotropic peptides and penile erection ↗